yourEra review

yourEra publishes a dedicated microdosing protocol at its own stated rate, on its own public page — which sounds unremarkable until you notice how much of this board hides per-dose pricing behind an intake quiz. Both molecules are available, an adjacent NAD+ line and an optional coaching-and-labs membership sit beside them, and it markets a 50-state clinician network. Against that: it is weekly injectable only, with no brand-name or oral route, it sits mid-market rather than cheap, and its independent footprint is thin enough that the 50-state and outcome claims are self-reported.

Mid-market pricing ($199 semaglutide / $299 tirzepatide) — above the cheapest compounders (~$99–$150)

yourEra (yourera.com) is a compounded GLP-1 and longevity telehealth practice that publishes its pricing openly: a dedicated microdosing protocol at $179/mo — the low-dose lane most directly relevant to a start-low approach — alongside compounded semaglutide at $199/mo and compounded tirzepatide (dual GIP/GLP-1) at $299/mo, plus an optional NAD+ line at $249/mo. An online intake is reviewed by a licensed clinician, then a weekly injectable is shipped; there is no brand-name or oral pathway. yourEra markets a 50-state licensed-clinician network, takes no insurance, and accepts HSA/FSA. An optional yourEra Optimum membership (+$149/mo) layers on 1:1 coaching, a nutritionist, at-home lab draws, and wearables.

Pricing structure

Varies by dose, plan or tier

Consult

Included in the price

Compounding

Not publicly identified

Labs

Optional

Dietitian support

Not included

• Dedicated microdosing protocol at $179/mo — a low-dose lane directly suited to a start-low approach
• Transparent, publicly listed pricing on its own site — many compounded competitors hide price behind a quiz
• Both semaglutide and tirzepatide, plus an adjacent NAD+ longevity line and an optional coaching/nutritionist/at-home-lab bundle
• Markets a 50-state licensed-clinician network; no insurance required and HSA/FSA accepted

• Compounded semaglutide/tirzepatide are not FDA-approved and are not the same as Wegovy/Ozempic/Zepbound; intentional microdosing is off-label and unproven
• No brand-name and no oral option — weekly injectable only
• Thin independent footprint with few third-party reviews; the 50-state and efficacy claims are self-reported

Intentional GLP-1 microdosing is off-label and unproven — no randomised trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• Microdosing tirzepatide
• What microdosing GLP-1 costs
• Microdose & reconstitution calculator
• Titration planner

yourEra is one of 24 low-dose GLP-1 providers we track. The board lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.